EP3458102
Lyfjaafleiður af mótefni gegn cMet og aðferðir við notkun þeirra
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
17.5.2017EP published:
17.6.2020EP application number:
17728311.6
EP translation filed:
12.7.2020Grant published:
15.8.2020EPO information:
European Patent Register
Max expiry date:
16.5.2037Expiry date:
16.5.2026Next due date:
31.5.2026
Title:
ANTI-CMET ANTIBODY DRUG CONJUGATES AND METHODS FOR THEIR USE
Timeline
Today
17.5.2017EP application
17.6.2020EP Publication
12.7.2020Translation submitted
15.8.2020Registration published
16.5.2026Expires
Owner
Name:
AbbVie Manufacturing Management Unlimited CompanyAddress:
70 Sir John Rogerson’s Quay, Dublin D02 R296, IE
Inventor
Name:
REILLY, Edward B.Address:
Libertyville Illinois 60048, US
Name:
NAUMOVSKI, LouieAddress:
Los Altos California 94022, US
Name:
ALLAN, Christian B.Address:
San Mateo California 94403, US
Name:
WANG, JieyiAddress:
Belmont California 94002, US
Name:
ANDERSON, Mark G.Address:
Grayslake Illinois 60030, US
Name:
AFAR, Daniel E.Address:
Los Altos Hills California 94022, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201662337796 PDate:
17.5.2016Country:
US
Classification
Categories:
A61K 47/68
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 12.4.2021
Expires: 16.5.2022
Payer: Örn Þór slf.
Number: 6
Paid: 22.4.2022
Expires: 16.5.2023
Payer: Árnason Faktor ehf.
Number: 7
Paid: 12.4.2023
Expires: 16.5.2024
Payer: Árnason Faktor ehf.
Number: 8
Paid: 12.4.2024
Expires: 16.5.2025
Payer: Árnason Faktor ehf.
Number: 9
Paid: 5.5.2025
Expires: 16.5.2026
Payer: Árnason Faktor ehf.